We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.
- Authors
Thunnissen E; Bubendorf L; Dietel M; Elmberger G; Kerr K; Lopez-Rios F; Moch H; Olszewski W; Pauwels P; Penault-Llorca F; Rossi G; Thunnissen, Erik; Bubendorf, Lukas; Dietel, Manfred; Elmberger, Göran; Kerr, Keith; Lopez-Rios, Fernando; Moch, Holger; Olszewski, Wlodzimierz; Pauwels, Patrick
- Abstract
In non-small cell lung cancer, epidermal growth factor receptor gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements have a major impact upon the level of response to treatment with specific tyrosine kinase inhibitors. This review describes the molecular basis of ALK inhibition, summarizes current data on the effectiveness and safety of ALK inhibition therapy, describes the different testing methodologies with their advantages and disadvantages, provides a suggested testing algorithm and puts forward a proposal for an external quality assessment program in ALK testing.
- Publication
Virchows Archiv: European Journal of Pathology, 2012, Vol 461, Issue 3, p245
- ISSN
0945-6317
- Publication type
journal article
- DOI
10.1007/s00428-012-1281-4